1.
Acta Pharmaceutica Sinica B
;
(6): 2313-2322, 2020.
Artículo
en Inglés
| WPRIM
| ID: wpr-881113
RESUMEN
Prostate cancer (PCa) patients who progress to metastatic castration-resistant PCa (mCRPC) mostly have poor outcomes due to the lack of effective therapies. Our recent study established the orphan nuclear receptor ROR